Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling.
Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling.
复制标题
DOI:
10.1038/s41598-018-21087-5
复制
发表时间:
2018-02-13
影响因子:
4.6
通讯作者:
Touyz RM
中科院分区:
文献类型:
--
作者:
Nguyen Dinh Cat A;Callera GE;Friederich-Persson M;Sanchez A;Dulak-Lis MG;Tsiropoulou S;Montezano AC;He Y;Briones AM;Jaisser F;Touyz RM
Activation of aldosterone/mineralocorticoid receptors (MR) has been implicated in vascular dysfunction of diabetes. Underlying mechanisms are elusive. Therefore, we investigated the role of Rho kinase (ROCK) in aldosterone/MR signaling and vascular dysfunction in a model of diabetes. Diabetic obese mice (db/db) and control counterparts (db/+) were treated with MR antagonist (MRA, potassium canrenoate, 30 mg/kg/day, 4 weeks) or ROCK inhibitor, fasudil (30 mg/kg/day, 3 weeks). Plasma aldosterone was increased in db/db versus db/+. This was associated with enhanced vascular MR signaling. Norepinephrine (NE)-induced contraction was increased in arteries from db/db mice. These responses were attenuated in mice treated with canrenoate or fasudil. Db/db mice displayed hypertrophic remodeling and increased arterial stiffness, improved by MR blockade. Vascular calcium sensitivity was similar between depolarized arteries from db/+ and db/db. Vascular hypercontractility in db/db mice was associated with increased myosin light chain phosphorylation and reduced expression of PKG-1α. Vascular RhoA/ROCK signaling and expression of pro-inflammatory and pro-fibrotic markers were exaggerated in db/db mice, effects that were attenuated by MRA. Fasudil, but not MRA, improved vascular insulin sensitivity in db/db mice, evidenced by normalization of Irs1 phosphorylation. Our data identify novel pathways involving MR-RhoA/ROCK-PKG-1 that underlie vascular dysfunction and injury in diabetic mice.
登录
查看更多内容
DOI:
10.1161/hypertensionaha.113.01967
发表时间:
2014-03
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
Galmiche G;Pizard A;Gueret A;El Moghrabi S;Ouvrard-Pascaud A;Berger S;Challande P;Jaffe IZ;Labat C;Lacolley P;Jaisser F
通讯作者:
Jaisser F
影响因子:
7.3
作者:
Guilluy, C;Sauzeau, V;Loirand, G
通讯作者:
Loirand, G
影响因子:
3.7
作者:
Noda K;Nakajima S;Godo S;Saito H;Ikeda S;Shimizu T;Enkhjargal B;Fukumoto Y;Tsukita S;Yamada T;Katagiri H;Shimokawa H
通讯作者:
Shimokawa H
影响因子:
7.7
作者:
Cat, Aurelie Nguyen Dinh;Antunes, Tayze T.;Touyz, Rhian M.
通讯作者:
Touyz, Rhian M.
影响因子:
4.8
作者:
Bruder-Nascimento T;da Silva MA;Tostes RC
通讯作者:
Tostes RC